CA 125 (Ovarian Cancer Screen) Blood Test

<h2>CA 125 (OVARIAN CANCER SCREEN) <span style="color: rgb(189, 51, 50);">BLOOD TEST</span> </h2> <p>CA 125 (Ovarian Cancer Screen) testing involves a blood test that measures the concentration of this protein in the bloodstream. It is commonly used as a tool to aid in the diagnosis of ovarian cancer, especially in cases where symptoms or imaging findings suggest the possibility of this disease. Elevated levels of CA 125 can indicate the presence of ovarian cancer, but it is important to note that other non-cancerous conditions, such as endometriosis and uterine fibroids, can also lead to increased CA 125 levels.</p> <p>In addition to its diagnostic utility, CA 125 is also used for monitoring the response to treatment and assessing disease progression in individuals with ovarian cancer. A decline in CA 125 levels over time can indicate a positive response to therapy, while a rise in CA 125 levels may suggest recurrence or progression of the disease. Serial monitoring of CA 125 levels allows healthcare professionals to make informed decisions regarding treatment adjustments and to evaluate the effectiveness of interventions.</p> <h2>1 Biomarker</h2> <div class="funky_list"> <ol role="list" style="--length: 2;"> <li style="--i: 1;"> <h4>CANCER BIOMARKER<br> </h4> <p>- CA 125<br>- Turnaround time for this test is around 5 working days</p> </li> </ol> </div>